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INTRODUCTION
Obstructive sleep apnea syndrome (OSAS) is seen in all age gr-
oups. The prevalence is greater in men (24%) than women (9%)
(1). The most common complaints that bring patients to a physi-
cian are snoring and excessive daytime sleepiness (EDS). The syn-
drome is associated with arousals and fragmented sleep due to
an anatomic partial collapse or total obstruction of the upper air-
way during sleep. Generally, as severity increases over time in
OSAS, so do the pathophysiologic derangements which cause
morbidities and mortality including hypertension, arrhythmias,
myocardial infarction, stroke and sudden death. However, the
behavioral derangements tend to show up far sooner than the
pathophysiologic problems, as EDS creates severe decrements in
quality of life. These findings substantiate the necessity for diag-
nosis and treatment of OSAS.
Besides weight reduction, surgical management was the first
treatment modality available for OSAS. Some of the first subjects
to undergo surgery for an anatomic narrowing or blockage of the
upper airway during sleep were those afflicted with the Pickwick-
ian syndrome (obesity-hypoventilation syndrome). Tracheotomy
was the sole surgical procedure available during this period (2)
and since it was life saving in these circumstances it was often used
for patients with nocturnal upper airway obstruction. The tracheo-
tomy was not well tolerated or accepted by most patients even
as a method to improve the quality of life, or even to extend life
itself. In the early 70’s the term used to describe nocturnal airway
obstruction was hypersomnia with periodic apnea (HPA), later
revised to be called OSAS.
Over the years our knowledge of sleep disorders has evolved
to such an extent that the field is now a recognized specialty in
medicine and will be, in the future, a specialty in Otolaryngology
Head and Neck Surgery as well as other interested surgical fields.
The coupling of medicine and surgery for the definitive man-
Surgical treatment of obstructive sleep apnea syndrome (OSAS) has been available in some form for greater than three
decades. Early management for airway obstruction during sleep relied on tracheotomy which although life saving was
not well accepted by patients. In the early eighties two new forms of treatment for OSAS were developed. Surgically a
technique described as a uvulopalatopharyngoplasty (UPPP) was used to treat the retropalatal region for snoring and sleep
apnea. Concurrently sleep medicine developed a nasal continuous positive airway pressure (CPAP) device to manage
nocturnal airway obstruction. Both of these measures were used to expand and stabilize the pharyngeal airway space dur-
ing sleep. The goal for each technique was to limit or alleviate OSAS. Almost 30 yr later these two treatment modalities
continue to be the mainstay of contemporary treatment. As expected, CPAP device technology improved over time along
with durable goods. Surgery followed suit and additional techniques were developed to treat soft and bony structures of
the entire upper airway (nose, palate and tongue base). This review will only focus on the contemporary surgical meth-
ods that have demonstrated relatively consistent positive clinical outcomes. Not all surgical and medical treatment modal-
ities are successful or even partially successful for every patient. Advances in the treatment of OSAS are hindered by the
fact that the primary etiology is still unknown. However, both medicine and surgery continue to improve diagnostic and
treatment methods. Methods of diagnosis as well as treatment regimens should always include both medical and surgical
collaborations so the health and quality of life of our patients can best be served.
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Reviewagement of OSAS results in optimal treatment. This combination
provides the patient with options, as not all patients will accept
one approach or the other as their initial treatment modality. 
Over time both medicine and surgery have recognized that the
obstructive process in sleep disorders breathing is predominate-
ly a diffuse upper airway problem. Hence, nocturnal narrowing
or complete obstruction may be localized to one or two areas but
there is usually diffuse involvement which encompasses the entire
pharyngeal upper airway passages. The three major regions are
the nasal cavity, retropalatal (RP) and retrolingual (RL) regions.
Difficulty of treatment and rates of success become more prob-
lematic as the level of these three regions descends. This is due
to the fact that tissue volume increases significantly from the nose
to the base of tongue. 
Conservative medical therapy is usually recommended first as
it is non invasive. Medical sleep centers provide several treatment
methods for OSAS such as sleep hygiene, weight loss, dental spl-
ints and continuous positive airway pressure devices (CPAP/Bi-
PAP). There are also surgical procedures presently available to
provide for a logical reconstruction of the upper airway.
Contemporary surgical procedures offer reconstruction of the
airway from the nose and palatal level to the tongue base (3, 4).
PRE-SURGICAL EVALUATION
A standard evaluation should include attended overnight poly-
somnography, a comprehensive history, and a head and neck
physical examination. Diagnostic evaluation methods should be
considered on all patients who are candidates for surgical inter-
vention. Fiberoptic nasopharyngoscopy and lateral cephalomet-
ric analysis have been the primary diagnostic tools for many years.
Sleep endoscopy may have a role in diagnosis but at this time it
is considered investigational, mainly due to the fact that sleep in-
duced by medication may not be the same as non-medicated sl-
eep (5, 6). Newer technology using 3-D imaging (magnetic reso-
nance imaging [MRI] or computed tomography [CT]) coupled
with software programs such as Dolphin Imaging
� (Chatsworth,
CA, USA) may help to assess constricted regions (minimal cross
sectional areas, MCSA) as well as provide volumetric measure-
ments of the airway (nose to larynx) (Fig. 1). Non-intrusive vis-
cous flow modeling using steady-state numerical formulation
Reynolds averaged navier-stokes (RANS), and a high fidelity
unsteady large eddy simulation (LES) is being studied for future
use in OSAS. Combined these two computational fluid dynam-
ics (CFD) methods can be extremely helpful in assessing sites of
obstruction pre-operatively and outcomes results post-operative-
ly. These metrics can also examine the actual airflow character-
istics of the upper airway in subjects with OSAS pre and post treat-
ment (CPAP and/or surgery) (7). Computational fluid dynamics
applying RANS and LES are generally used as an investigation-
al tool but in the future may become a routine method of airway
and airflow evaluation. It is cautioned that no one test or proce-
dure should be relied on to make diagnostic and treatment deci-
sions. 
METHODS AND TREATMENTS
The indications for treatment of OSAS are basically the same re-
gardless of whether the patient is to be treated medically or sur-
gically. However, the sleep study component of the surgical work
up is slightly different; if surgery is proposed a full night attend-
ed polysomnogram (PSG) should be used. This is important since
data from the PSG will reflect all parameters of sleep and breath-
ing to establish a true surgical pre-treatment baseline. Snoring and
EDS combined with an abnormal PSG are the main indications
for treatment.
Medical
Although primary management is usually done by sleep medicine
physicians, a surgeon should have a good grasp of the medical
sleep protocols. Medical treatment concentrates on the most con-
servative methods and moves forward appropriately: sleep hyg-
iene, weight loss, dental splints and nasal pressure devices (CPAP/
BiPAP). The two most important are weight loss and pressure
devices and of those two nasal pressure devices are the most suc-
cessful.
Surgical
Surgical techniques for OSAS are used in centers around the wor-
ld. There are many new surgical techniques that are being eval-
uated. Unfortunately, at present there is inadequate evidence ba-
sed literature to support these techniques. In the future some of
these new technologies may show sufficient safety and efficacy









Hyoid myotomy suspension (HMS)
Bi-maxillary advancement (BMA)
The contemporary surgical methods focus on procedures to
treat the three major regions of obstruction in OSAS (nasal, retro-
palatal and retrolingual). Over the years many surgeons have de-
veloped new techniques or modified existing methods to treat
these areas. The oldest procedure is tracheotomy which can be
temporary or permanent and is considered as a by-pass proce-
dure of the upper-airway. It is not well tolerated by most patients
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icant co-morbidities. CPAP was recognized early as a successful
alternative to tracheotomy in maintaining a patent airway post-
operatively in OSAS surgery, and has all but eliminated the need
for that procedure in most cases (8). 
Nasal obstruction/reconstruction
Nasal obstruction, if present, is treated with techniques that will
improve the airway at the turbinates, septum and alar valve, and
eliminate alar collapse and bony deformities. The procedures are
used to improve CPAP usage or for relief of severe nasal obstruc-
tion. Nasal surgery for OSAS can help to decrease negative pres-
sure breathing during sleep (9-13). It should be remembered that
seldom does isolated nasal surgery resolve OSAS. An example
of bilateral alar collapse is seen in Fig. 2 (14).
Retropalatal obstruction/reconstruction 
This is an important portion of the airway as OSAS patients often
demonstrate floppy and/or bulky tissues along with excessive ti-
ssues at the lateral pharyngeal walls. The palatal tissues in OSAS
are the most compliant of the upper airway inlet and hence eas-
ily collapsible during sleep. Dr. Shiro Fujita was the first to bring
UPPP to the United States. This technique conservatively remo-
ved portions of the palatal edge and uvula. Over the years the





Fig. 1. (A) is a 3-D CT taken awake and supine with software reconstruction specifically to assess characteristics of the airway. (B) is an axial sec-
tion showing the minimum cross sectional area (MCSA) of the pharyngeal airway which measures 31.0 mm
3. This is a significant narrowing at
that level. (C) has a total airway volume of 23,372.2 mm
3 from the inlet to the outlet outlined in pink. (D) is a reconstruction of the facial skeleton
along with an outline of soft tissues. This allows an exposure of the airway that is not seen in traditional radiographs.technique has been modified by many surgeons (4, 15-19). Overall
UPPP, when done conservatively, is an excellent surgical pro-
cedure for the retropalatal level. If applied when little or no obs-
truction is noted at the retrolingual area (base of tongue) its suc-
cess is reasonably good. If there is undetected tongue base obstr-
uction the control rate at the retropalatal level will be compro-
mised. It is prudent to remove tonsils if they are in any way part
of the obstruction. In patients who have been carefully selected
for upper airway reconstruction and whose site of primary obstr-
uction is at the retropalatal level (Fujita Type l) (20) the cure rate
may be 80 to 90% (21). In unselected patients (Fujita Type II or
III) (Table l) this rate will fall to a low of 5 to 30% (4). It should
be remembered that if the palate is part of nocturnal obstruction
and not treated, but the tongue base is treated, the likelihood of
overall control will be greatly lessened. 
Retrolingual obstruction/reconstruction 
Tongue base obstruction has been documented in OSAS by EMG
studies, fiberoptic nasopharyngoscopy, radiographic cephalo-
grams, and CT or MRI imaging. A systematic evaluation of the
entire airway is always necessary, especially for the tongue base,
lingual tonsils, epiglottis and larynx. The obstruction of the retro-
lingual (base of tongue) region is a very complex problem since
the elasticity of the tongue tissue while awake is different than
during sleep. This region may be bypassed by tracheotomy or
be treated by either making more room for the tongue or by re-
ducing the tongue size. There are soft tissue techniques to remove
the mid portion of the tongue base using laser midline glossec-
tomy (22), partial glossectomy (23) or volumetric shrinkage by
radiofrequency energy (24). Due to problems with bleeding, post-
op edema and speech deficits, the first two techniques have long
since been abandoned by most surgeons. Radiofrequency has
been shown to shrink tongue tissues (24). The technique requires
multiple treatments over time with a period between treatments
of 4-6 weeks. This will give sufficient time to allow healing and
shrinkage. In tongue base radiofrequency (RF) treatment there
may be partial relapse which can require retreatment (25). We
consider RF to the tongue base to be a valuable adjunctive pro-
cedure. It is even more successful is the treatment of turbinate
hypertrophy for CPAP users (26).
Skeletal advancements can be used to place tension on the ton-
gue so that during sleep it does not fall as far back into the pos-
terior airway space (PAS). This procedure is referred to as GA
(Fig. 3) (27-33). This is a simple technique that does not move the
teeth or jaw and therefore does not interfere with the dental bite.
The genioglossus tubercle is located at the lingual portion of the
chin in the floor of the mouth. The tendons of the genioglossus
muscle are embedded into the tubercle. When the jaw moves
forward (as in an emergency jaw thrust used in an obstructed
airway) the tongue base also moves forward, increasing the PAS.
The procedure has limits for two reasons. First, an osteotomy of
the anterior mandible is necessary to slide the geniotubercle for-
ward and advance the tongue. The segment can only be moved
forward the thickness of the individual’s chin which is usually
12-15 mm. Secondly, the outcomes of this advancement will be
less favorable if the tongue muscle does not have good tension
following advancement. It should be pointed out that this proce-
dure was not developed to gain significant anterior movement
of the tongue base, but instead to place sufficient tension on the
tongue so it would not collapse into the PAS. In addition, this
procedure does not gain any room for the tongue as the jaw itself
is not moved. At this time we have no way to pre-operatively
predict the amount of tension that will be achieved when the
tongue is advanced. Fortunately, most advancements create ade-
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Fig. 2. Alar collapse during inspiration is very common in obstructive sleep apnea syndrome (OSAS). Alar grafts can improve patency when pla-
ced bilaterally along the alar rim.
Alar collapse seen often in OSAS
Table 1. Classification of obstructive region by Dr. Shiro Fujita (20)
Type l       Palate (normal tongue base)
Type ll      Palate and base of tongue
Type lll     Base of tongue (normal palate)quate tension on the genioglossus muscle.
A hyoid myotomy and suspension may be used at the same time
as the genioglossus advancement. However, we have abandoned
most cases of combined usage since it is often unclear whether
the additional technique is necessary. It is, however, still used as
an adjunctive technique at our center. 
A more aggressive procedure for the tongue base, usually saved
for incomplete treatment or failure of the more conservative sur-
gery above, is the forward movement of the lower jaw and mid-
face (BMA). It gives the tongue more room and also places
additional tension on the tongue base (Fig. 4). Speech has not
been affected in any of these procedures. The techniques using
skeletal procedures for the retrolingual level have been used by
our group for the past 25 yr and have proven to be an effective
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Fig. 3. Genioglossus advancement. (A) Cadaver model with marking of rectangular cut on bone. (B) Rectangular cut (2×1 cm) with a thin sagit-
tal saw from labial to lingual cortex to include the geniotubercle where the tendons of the genioglossus are attached. (C) Segment pushed gen-
tly into the floor of the mouth for hemostasis if needed. (D) Advance segment so the lingual cortex is pulled forward and turned enough so the
lingual cortex is lying on the labial cortex. (E) The outer cortex is removed and a small titanium screw is placed at the inferior border. (F) Pre op.








Fig. 4. Pre and post-op bi-max: 64 yr old male with severe Sleep Apnea Syndrome. Note improvement of the posterior airway space from bi-maxil-
lary advancement.and safe method for controlling upper airway collapse in OSAS.
Our published clinical outcomes and cure rate for Phase I is 42%
to 75% depending on the severity of the disorder (28) and simi-
lar results have been confirmed by others (34-43). Phase II (bi-
maxillary surgery) has documented cure rates of 90% or
greater (44-63). It is important to be aggressive in Phase II surgery
as the best results are usually directly related to the distance of
your bi-maxillary advancements (Fig. 5). Our definition of respon-
der or cure for clinical outcomes can be seen in Table 2. Long
term clinical outcomes published by our center in 2000 showed
stable results (64). Risk management and complications should
always be on the top of the list for our patients and our field (65).
Twenty years ago we developed a Phase I and Phase II treat-
ment protocol predicated on evidence-based medicine principles.
It is described as the Stanford University Powell-Riley Protocol.
The rationale for this protocol was: decreased risk of over oper-
ating, treated conservatively because outcomes are difficult to
predict, decreased hospital stay, limited postoperative risk, caused
less trauma and pain and was better accepted by most patients.
Powell-Riley phase I protocol 
Three regions of the upper airway are treated as directed by the
clinical work up using the most conservative surgery for each, but
only including treatment at that level if it was considered suffi-
ciently obstructed.
Nasal: Correct nasal obstruction depending on anatomical de-
formity (septum, turbinates, nasal valve deformities, alar collapse
and bony deformities).
Retropalatal: UPPP or equivalent and tonsillectomy if tonsils
present.
Retrolingual: Genioglossus advancement, with or without hyoid
myotomy and suspension.
After phase one is completed a period of 4-6 months is allowed
for sufficient healing, weight stabilization and neurologic equili-
bration. Then a repeat polysomnogram accompanied with a sleep
assessment and clinical examination is done to assess the clinical
outcomes. Those patients who are unchanged or incompletely
treated are offered either further surgery (Phase II) or medical
management (CPAP). 
Powell-Riley phase II protocol
If the protocol has been followed to this point the only region
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Pre op s/p genioglossus Pre op MMO s/p MMO
Fig. 5. Forty one year old Asian woman, AHI 28.3, low sat 84%, severe EDS, BMI 22 kg/m
2; surgical procedure for OSAS: BMA/GA with BMA
advancement of 26 mm and GA advancement of 12 mm for a total advancement of 38 mm. Post op: AHI 2.5, low sat 91%, resolved EDS, BMI
21 kg/m
2. AHI: apnea-hypopnea index; EDS: excessive daytime sleepiness; BMI: body mass index; OSAS: obstructive sleep apnea syndrome;
BMA/GA: bi-maxillary advancement/genioglossus advancement.
Pre op 12-01
Table 2. Definition of responder or cure: (Powell-Riley) Criteria must
include 1-3 below or 4 
1. AHI ≤20 and /or at least a reduction in the AHI of 50% ( for any AHI that
is less than 20 episodes per hour of sleep, example if the AHI is 16 then
it must be by definition 8.0 after treatment to call it a cure) 
2. Sa02 ≥90% or a minimal fall below 90%
3. Normalization of sleep architecture
4. Equivalent comparison to nasal CPAP/BiPAP results on the second night
of titration 
5. Resolution of EDS
AHI: apnea-hypopnea index; EDS: excessive daytime sleepiness.that should be left incompletely treated is retrolingual (base of
tongue). A choice now is made among the remaining methods:
Bi-maxillary advancement surgery, tracheotomy or nasal CPAP.
Other techniques that could be considered to make additional
room for the tongue are the laser midline glossectomy and lin-
gualplasty, or partial glossectomy, although these procedures are
seldom used by our center for Phase II. Base of tongue reduction
using radiofrequency may become an adjunctive alternative to
Bi-maxillary advancement surgery in some very select patients.
Powell’s pearl “the algorithm”
The question I am most often asked by my patients, or while tea-
ching residents, visitors or travelling is, what is your algorithm
for the treatment of OSAS? From the surgical standpoint the an-
swer is that there is no such algorithm that can be applied to all
patients. It is almost impossible to state, even in an individual pa-
tient, because of the multifactorial etiologies in this syndrome.
This is one of the reasons a systematic diagnostic and phased pro-
tocol is applied at our sleep center, but this does not suggest an
algorithm that would serve all patients. The question will contin-
ue to be asked until our field gains sufficient knowledge and un-
derstanding of sleep to permit a reliable and consistent answer.
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